Call Options Transactions Made in Q4 2022 in Kiniksa Pharmaceuticals, Ltd. (KNSA)
This table provides information about the institutional ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA) during Q4 2022. The information is specifically focused on institutions that hold call options of Kiniksa Pharmaceuticals, Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
86.1K+ 113.74% |
$983K - $1.47M
|
162K
$3.33M
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
CALL |
70K+ 200.0% |
$799K - $1.19M
|
105K
$2.16M
|
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
10.1K+ 40.56% |
$115K - $172K
|
35K
$721K
|
|
|
Feb 14, 2023
Q4 2022
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
5K+ 16.67% |
$57.1K - $85.3K
|
35K
$721K
|
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-87.1K- 81.48% |
$995K - $1.49M
|
19.8K
$408K
|